Showing 2191-2200 of 2527 results for "".
- FDA Says No to Evolus' Botox Rivalhttps://modernaesthetics.com/news/fda-says-no-to-evolus-botox-rival/2472089/The U.S Food and Drug Administration did not approve DWP-450, Evolus Inc's rival product to Allergan Plc's Botox, due to chemistry and manufacturing issues. As a result, the company pushed its estimate for the launch of the drug to the spring of next year. Read more
- Cutera Marks 20 Years of Innovationhttps://modernaesthetics.com/news/cuter-marks-20-years-of-innovation/2472102/Cutera, Inc. is celebrating 20 years of best-in-class product innovation with continued commitment to the industry and its providers, marking the milestone at the Annual Meeting of the American Society for Laser Medicine and Surgery in Dallas. In conjunction with the 20th&nbs
- Back by Popular Demand: Sciton's Bright Lights Big City BBL Tourhttps://modernaesthetics.com/news/back-by-popular-demand/2472107/Sciton. Inc.’s
- Game On: Revance Readies for Launch of their Botox Competitorhttps://modernaesthetics.com/news/game-on-revance-readies-for-launch-of-their-botox-competitor/2472111/With the advent of four new positions, Revance Therapeutics is expanding their commercialization team in anticipation of the product launc
- Revance, Mylan Partner to Develop Botox Biosimilarhttps://modernaesthetics.com/news/revance-mylan-partner-to-develop-botox-biosimilar/2472123/Mylan N.V. and
- Jacob Chacko, MD Joins Bonti's Board of Directorshttps://modernaesthetics.com/news/jacob-chackomd-joins-bontis-board-of-directors/2472135/Jacob Chacko, MD has joined Bonti’s Board of Directors. Dr. Chacko has served as the Chief Financial Officer of Ignyta, Inc. since May 2014. At Ignyta, he leads multiple functions, including Finance, Accounting, Investor Relations, Comm
- Cynosure's TempSure™ Envi Set to Debut at 2018 AAD Meetinghttps://modernaesthetics.com/news/cynosures-tempsure-envi-set-to-debut-at-2018-aad-meeting/2472144/Hologic's Cynosure division is launching TempSure™ Envi – an FDA-cleared advanced radiofrequency device. TempSure™ Envi heats the deep layers of skin to regenerate collagen and
- FDA OKs Describe Patch for Use with All Tattoo Removal Lasershttps://modernaesthetics.com/news/fda-oks-describe-patch-for-use-with-all-tattoo-removal-lasers/2472158/Merz North America’s DESCRIBE® PFD Patch is now cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal. The new FDA c
- Fat Reduction Following Treatment with BTL Vanquish Lasts Four Yearshttps://modernaesthetics.com/news/fat-reduction-following-treatment-with-btl-vanquish-lasts-four-years/2472169/Abdominal fat reduction achieved via BTL Vanquish and Vanquish ME lasts for at least four years, according to new long-term data released
- FDA Clears Thermage's FLX System for Smoothing Skinhttps://modernaesthetics.com/news/fda-clears-thermages-flxtm-system-for-smoothing-skin/2472182/The U.S. Food and Drug Administration (FDA) granted 510(K) clearance to Solta Medical’s new Thermage FLXTM System for smoothing skin on the face, eyes, and body. The Thermage FLX features a new optimized energy delivery algorithm, known